LDS/Medical Tests/Uniparental Disomy, FISH, Blood

Uniparental Disomy, FISH, Blood

Humans are diploid organisms, normally inheriting one copy of each chromosome from the mother and one from the father. Uniparental disomy (UPD) occurs when both copies of a chromosome, or part of a chromosome, are inherited from one parent, with no contribution from the other. The condition was first described in 1988 in a child with cystic fibrosis who had inherited two copies of a pathogenic CFTR allele from the carrier mother.There are two main forms of UPD, Isodisomy where both copies are identical and originate from a single parental chromosome and heterodisomy, where both copies are from the same parent but represent different homologues. UPD usually results from errors in meiotic segregation (nondisjunction in meiosis I or II) or from a trisomy rescue mechanism, in which an embryo initially inherits three copies of a chromosome, and loss of one result in both remaining copies coming from the same parent. UPD has been implicated in multiple genetic disorders, particularly those involving imprinted regions of chromosomes 6, 7, 11, 14, 15, and 20. Examples include:

  • Transient neonatal diabetes mellitus (chromosome 6q24.2) with neonatal hyperglycemia, usually resolving within months.
  • Russell-Silver syndrome (chromosome 7, 11p15) or intrauterine growth restriction, relative macrocephaly, facial asymmetry.
  • Beckwith-Wiedemann syndrome (chromosome 11p15), congenital overgrowth with increased risk of embryonal tumors.
  • Temple syndrome (chromosome 14) with developmental delay, hypotonia, truncal obesity, short stature.
  • Prader-Willi syndrome (paternal loss on chromosome 15q11-q13) with neonatal hypotonia, intellectual disability, childhood-onset obesity, behavioral abnormalities.
  • Angelman syndrome (maternal loss on chromosome 15q11-q13) a severe intellectual disability, seizures, microcephaly, absent speech.
  • Aids in the diagnosis of UPD-related genetic disorders
  • Useful in the evaluation of patients with unexplained developmental delay, congenital anomalies, or growth disorders
  • Supports investigation of suspected mosaicism or imprinting-related syndromes
  • Guides genetic counseling for families at risk

Positive: Detection of polymorphic markers consistent with UPD. Supports diagnosis of an imprinting disorder.

Negative: No UPD detected. Does not exclude other genetic or epigenetic disorders; correlation with clinical and laboratory findings required.

Negative (No polymorphic markers detected).

Fluorescent in-situ hybridization (FISH).

Whole blood, EDTA or heparin.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7 days
Chromosomal microarray (CMA), DNA methylation analysis for imprinting disorders, Targeted gene sequencing as clinically indicated.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login